HealthStream (HSTM) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenues reached $73.1 million, up 3.9% year-over-year, with record adjusted EBITDA of $17.7 million and net income up 48% to $5.7 million; diluted EPS rose to $0.19 from $0.13.

• 96% of revenues are subscription-based, supporting stable, recurring income streams.

• Strong sales pipelines in CredentialStream, ShiftWizard, and analytics/API products, with expansion into new markets such as nursing schools and direct-to-professional channels.

• The company continues to focus on its One HealthStream platform strategy, leveraging hStream technology for interoperability and value enhancement.

• Board declared a quarterly cash dividend of $0.028 per share, payable November 15, 2024.

Financial highlights

• Q3 2024 revenues were $73.1 million, up 3.9% year-over-year; adjusted EBITDA was $17.7 million, up 9%, with a margin of 24.2%.

• Net income for Q3 2024 was $5.7 million, up from $3.9 million in Q3 2023; operating income was $6.5 million, up 33.6%.

• Subscription revenues were $69.9 million (96% of total), up 3.6%; professional services revenues were $3.2 million, up 10.8%.

• Gross margin for Q3 2024 was 66.5%.

• Cash and investment balances at $94.9 million, with no debt and a $50 million unused credit facility.

Outlook and guidance

• 2024 revenue guidance revised to $290–$292 million, slightly lower due to slower customer content consumption.

• Net income guidance for 2024 is $18.5–$19.5 million; adjusted EBITDA guidance raised to $66–$67.5 million.

• Capital expenditures for 2024 expected to be $28–$30 million.

• Medium-term objectives: revenue growth of 7–10% annually, gross margin of 65–68%, and adjusted EBITDA margin of 21–24%.

• Management expects existing cash, operations, and credit to be sufficient for all needs for at least the next 12 months.